As earlier published that Demis Hassabis, the CEO of Google DeepMind won the Nobel Prize, but interestingly, he did not win it for physics.
DeepMind Introducing AlphaGenome
Contrary to the usual belief, he has won it for the outstanding achievement in chemistry.
To be specific, it is the kind of chemistry that goes into our bodies inside our genes and DNA.
Following this development, the DeepMind has introduced a new artificial intelligence model AlphaGenome now.
Basically, it is a new AI model which is specifically tuned to accurately predict how individual mutations in human DNA affect their functions.
In simple words, the AI will be utilised in helping the scientists and doctors in better understanding the genome functions.
This advanced AI model, developed by DeepMind, is said to bring a major leap in the research around genome.
When it comes to this human genome, it is a complete set of genetic instructions.
You can think of it as a comprehensive instruction manual which is holding the data to build and operate a living thing.
AlphaGenome, AI To Decode DNA Changes Impacting Human Health
Notably, the AI modal genetic material primarily consists of DNA.
Coming to Genomes, they can influence everything from physical traits of a human being to possible risks of diseases like cancer.
It appears that a small change in our DNA can bring in major effects to our health.
So far, understanding of the genes and how these changes work at a molecular level is one of the biggest challenges for biologists.
With this initiative, DeepMinds AlphaGenome AI aims to help researchers in solving these answers by providing deeper insights into genome mechanisms.
This would be helpful especially in the parts that don’t directly code for proteins but still play critical roles in regulating our genes.
According to the companythe researchers are already using AlphaGenome to explore how certain genetic mutations may lead to cancer.
During one test, they have accurately predicted how a mutation linked to leukaemia could activate a harmful gene, confirming previous experimental findings.
Presently, AlphaGenome is available through an API for non-commercial, research-focused use.
As we know that it is not approved for clinical diagnosis but Google says the AI tool can help scientists identify which mutations are most likely to cause disease.
The company claims that the model is still evolving, and future versions may cover more species, cell types, or biological processes.
